Valuation Mangalam Drugs & Organics Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. 07:05:08 2026-10-14 EDT			5-day change	1st Jan Change
32.44 ^INR	+1.22%		-1.96%	+17.92%

08-17	Mangalam Drugs and Organics Limited Discloses Default on Bank Loan Accounts with Bank of Baroda and Bank of Maharashtra	CI
08-12	Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	1,573	1,628	1,549	1,466	1,175	439.1
Change	-	3.47%	-4.86%	-5.31%	-19.89%	-62.62%
Enterprise Value (EV) ¹	2,264	2,487	2,407	2,525	2,111	1,560
Change	-	9.85%	-3.22%	4.87%	-16.37%	-26.13%
P/E	5.63x	8.28x	122x	-16.2x	17.5x	-0.99x
PBR	1.2x	1.08x	1.02x	1.08x	0.79x	0.43x
PEG	-	-0.3x	-1.3x	0x	-0x	0x
Capitalization / Revenue	0.41x	0.36x	0.42x	0.4x	0.37x	0.19x
EV / Revenue	0.6x	0.56x	0.65x	0.69x	0.66x	0.67x
EV / EBITDA	4.34x	5.65x	9.99x	32.9x	6.39x	-8.93x
EV / EBIT	5.08x	7.01x	16.5x	90.2x	10.8x	-4.8x
EV / FCF	-8.49x	-10.4x	-54.9x	-37.3x	18.2x	30.9x
FCF Yield	-11.8%	-9.58%	-1.82%	-2.68%	5.51%	3.23%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	17.67	12.42	0.8	-5.731	4.246	-28.05
Distribution rate	-	-	-	-	-	-
Net sales ¹	3,801	4,476	3,702	3,674	3,176	2,321
EBITDA ¹	521.9	440.6	241.1	76.84	330.2	-174.6
EBIT ¹	445.5	355	146.3	27.98	195.6	-324.6
Net income ¹	279.7	196.6	12.7	-90.72	67.21	-444
Net Debt ¹	691.1	859.5	858.6	1,058	936.4	1,121
Reference price ²	99.40	102.85	97.85	92.65	74.22	27.74
Nbr of stocks (in thousands)	15,828	15,828	15,828	15,828	15,828	15,828
Announcement Date	9/2/21	9/2/22	9/6/23	9/4/24	9/7/25	8/31/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.19x	12.03x	25.3x	0.59%	1,040B
JOHNSON & JOHNSON	36.75x	6.12x	17.02x	2.15%	599B
ABBVIE INC.	34.92x	8.07x	16.64x	2.53%	485B
MERCK & CO., INC.	109.67x	5.8x	24.85x	2.4%	350B
ROCHE HOLDING AG	19.42x	4.74x	11.78x	2.78%	345B
NOVARTIS AG	20.05x	5.27x	12.97x	3.02%	272B
ASTRAZENECA PLC	20.63x	4.17x	11.97x	2.12%	244B
AMGEN INC.	26.21x	6.79x	12.15x	2.44%	223B
GILEAD SCIENCES, INC.	-43.22x	6.62x	25.76x	2.23%	183B
Average	28.63x	6.62x	17.61x	2.25%	415.87B
Weighted average by Cap.	33.93x	7.73x	19.04x	1.93%